BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND OLIG2, OLIGO2, 10215, ENSG00000205927, BHLHB1, RACK17, PRKCBP2
17 results:

  • 1. Utility of combining olig2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
    Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
    Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Ewing's sarcoma of central nervous system: a clinicopathological analysis of six cases].
    Yang QY; Li H; Liu C; Bao ML; Fan QH; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1249-1254. PubMed ID: 38058042
    [No Abstract]    [Full Text] [Related]  

  • 3. [Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation].
    Tarakanova AV; Sharlay AS; Konovalov DM
    Arkh Patol; 2023; 85(1):10-15. PubMed ID: 36785957
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Adult Primary Pineal Alveolar Rhabdomyosarcoma with FOXO1 Gene Rearrangement and olig2 Expression: A Rare Case Report and Literature Review.
    Xie L; Wang W; Zhou H; Han Z; Xu J; Xu Z; Xiang J
    Int J Surg Pathol; 2022 Oct; 30(7):769-775. PubMed ID: 35188829
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Soft-tissue sarcoma with MN1-BEND2 fusion: A case report and comparison with astroblastoma.
    Yoshida A; Satomi K; Kobayashi E; Ryo E; Matsushita Y; Narita Y; Ichimura K; Kawai A; Mori T
    Genes Chromosomes Cancer; 2022 Jul; 61(7):427-431. PubMed ID: 35094441
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Oligosarcomas, IDH-mutant are distinct and aggressive.
    Suwala AK; Felix M; Friedel D; Stichel D; Schrimpf D; Hinz F; Hewer E; Schweizer L; Dohmen H; Pohl U; Staszewski O; Korshunov A; Stein M; Wongsurawat T; Cheunsuacchon P; Sathornsumetee S; Koelsche C; Turner C; Le Rhun E; Mühlebner A; Schucht P; Özduman K; Ono T; Shimizu H; Prinz M; Acker T; Herold-Mende C; Kessler T; Wick W; Capper D; Wesseling P; Sahm F; von Deimling A; Hartmann C; Reuss DE
    Acta Neuropathol; 2022 Feb; 143(2):263-281. PubMed ID: 34967922
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. C19MC amplification and expression of Lin28A and olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.
    Nambirajan A; Gurung N; Suri V; Sarkar C; Kumar A; Singh M; Sharma MC
    Childs Nerv Syst; 2021 Apr; 37(4):1067-1075. PubMed ID: 33236184
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not olig2.
    Salgado CM; Zin A; Garrido M; Kletskaya I; DeVito R; Reyes-Múgica M; Bisogno G; Donofrio V; Alaggio R
    Pediatr Dev Pathol; 2020; 23(6):424-430. PubMed ID: 32790583
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. olig2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
    Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
    J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. olig2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
    Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
    Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. olig2 is a marker of the fusion protein-driven neurodevelopmental transcriptional signature in alveolar rhabdomyosarcoma.
    Raghavan SS; Mooney KL; Folpe AL; Charville GW
    Hum Pathol; 2019 Sep; 91():77-85. PubMed ID: 31299267
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Primary central nervous system histiocytic sarcoma: A case report and review of literature.
    Ma S; Schild M; Tran D; Zhang X; Zhang WL; Shen S; Xu HT; Yang LH; Wang E
    Medicine (Baltimore); 2018 Jun; 97(26):e11271. PubMed ID: 29953002
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
    Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
    Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CNS high-grade neuroepithelial tumor with BCOR internal tandem duplication: a comparison with its counterparts in the kidney and soft tissue.
    Yoshida Y; Nobusawa S; Nakata S; Nakada M; Arakawa Y; Mineharu Y; Sugita Y; Yoshioka T; Araki A; Sato Y; Takeshima H; Okada M; Nishi A; Yamazaki T; Kohashi K; Oda Y; Hirato J; Yokoo H
    Brain Pathol; 2018 Sep; 28(5):710-720. PubMed ID: 29226988
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Fetal presentation of congenital fibrosarcoma of the meninges: case report and literature review.
    Marguet F; Bergogne L; Laurent N; Rousseau T; Laquerrière A
    Clin Neuropathol; 2015; 34(2):70-5. PubMed ID: 25492889
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic implications of IDH1-R132H and olig2 expression patterns in rare and challenging glioblastoma variants.
    Joseph NM; Phillips J; Dahiya S; M Felicella M; Tihan T; Brat DJ; Perry A
    Mod Pathol; 2013 Mar; 26(3):315-26. PubMed ID: 23041832
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
    Ishizawa K; Komori T; Shimada S; Hirose T
    Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.